These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35670949)

  • 41. Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis.
    Lassailly G; Caiazzo R; Ntandja-Wandji LC; Gnemmi V; Baud G; Verkindt H; Ningarhari M; Louvet A; Leteurtre E; Raverdy V; Dharancy S; Pattou F; Mathurin P
    Gastroenterology; 2020 Oct; 159(4):1290-1301.e5. PubMed ID: 32553765
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Noninvasive assessment of hepatic steatosis and fibrosis in patients with severe obesity.
    Coccia F; Testa M; Guarisco G; Bonci E; Di Cristofano C; Silecchia G; Leonetti F; Gastaldelli A; Capoccia D
    Endocrine; 2020 Mar; 67(3):569-578. PubMed ID: 31858390
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation Between Anthropometric Measurements and Non-alcoholic Fatty Liver Disease in Individuals With Obesity Undergoing Bariatric Surgery: Cross-Sectional Study.
    Reis SS; Callejas GH; Marques RA; Gestic MA; Utrini MP; Chaim FDM; Ramos AC; Chaim EA; Cazzo E
    Obes Surg; 2021 Aug; 31(8):3675-3685. PubMed ID: 33982243
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods.
    Soresi M; Cabibi D; Giglio RV; Martorana S; Guercio G; Porcasi R; Terranova A; Lazzaro LA; Emma MR; Augello G; Cervello M; Pantuso G; Montalto G; Giannitrapani L
    Biomed Res Int; 2020; 2020():5023157. PubMed ID: 32420347
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Weight Loss After Bariatric Surgery Predicts an Improvement in the Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score.
    Yeo SC; Ong WM; Cheng KSA; Tan CH
    Obes Surg; 2019 Apr; 29(4):1295-1300. PubMed ID: 30635812
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of bariatric surgeries on nonalcoholic fatty liver disease.
    Aldoheyan T; Hassanain M; Al-Mulhim A; Al-Sabhan A; Al-Amro S; Bamehriz F; Al-Khalidi H
    Surg Endosc; 2017 Mar; 31(3):1142-1147. PubMed ID: 27405478
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
    Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P
    Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of NAFLD and bariatric surgery on hepatic and adipose tissue mitochondrial biogenesis and respiration.
    Pedersen JS; Rygg MO; Chrøis K; Sustarsic EG; Gerhart-Hines Z; Wever Albrechtsen NJ; Serizawa RR; Kristiansen VB; Basse AL; Boilesen AEB; Olsen BH; Hansen T; Gluud LL; Madsbad S; Larsen S; Bendtsen F; Dela F
    Nat Commun; 2022 May; 13(1):2931. PubMed ID: 35614135
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bariatric surgery for non-alcoholic fatty liver disease in individuals with obesity (Base-NAFLD): protocol of a prospective multicenter observational follow-up study.
    Wei L; Li M; Zeng N; Liu Y; Bai R; Zhang N; Song J; Zhang P; Yao Q; Yang Z; Zhao X; Zhang Y; Zhang P; Zhang Z
    BMC Surg; 2021 Jun; 21(1):298. PubMed ID: 34167531
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery.
    Kazankov K; Tordjman J; Møller HJ; Vilstrup H; Poitou C; Bedossa P; Bouillot JL; Clement K; Grønbaek H
    J Gastroenterol Hepatol; 2015 Aug; 30(8):1293-300. PubMed ID: 25772748
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology.
    Bower G; Toma T; Harling L; Jiao LR; Efthimiou E; Darzi A; Athanasiou T; Ashrafian H
    Obes Surg; 2015 Dec; 25(12):2280-9. PubMed ID: 25917981
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score).
    von Schönfels W; Beckmann JH; Ahrens M; Hendricks A; Röcken C; Szymczak S; Hampe J; Schafmayer C
    Surg Obes Relat Dis; 2018 Oct; 14(10):1607-1616. PubMed ID: 30146425
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis.
    Taitano AA; Markow M; Finan JE; Wheeler DE; Gonzalvo JP; Murr MM
    J Gastrointest Surg; 2015 Mar; 19(3):429-36; discussion 436-7. PubMed ID: 25537957
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nonalcoholic Steatohepatitis Is Associated With Increased Mortality in Obese Patients Undergoing Bariatric Surgery.
    Goossens N; Hoshida Y; Song WM; Jung M; Morel P; Nakagawa S; Zhang B; Frossard JL; Spahr L; Friedman SL; Negro F; Rubbia-Brandt L; Giostra E
    Clin Gastroenterol Hepatol; 2016 Nov; 14(11):1619-1628. PubMed ID: 26492845
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HSCRP as surrogate marker in predicting long term effect of bariatric surgery on resolution of non-alcoholic steatohepatitis.
    Tan CH; Al-Kalifah N; Lee WJ; Ser KH; Lee YC; Chen JC
    Asian J Surg; 2019 Jan; 42(1):203-208. PubMed ID: 29804707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Systematic review of bariatric surgery liver biopsies clarifies the natural history of liver disease in patients with severe obesity.
    Bedossa P; Tordjman J; Aron-Wisnewsky J; Poitou C; Oppert JM; Torcivia A; Bouillot JL; Paradis V; Ratziu V; Clément K
    Gut; 2017 Sep; 66(9):1688-1696. PubMed ID: 27884920
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bariatric surgery and non-alcoholic fatty liver disease.
    Julià H; Benaiges D; Pedro-Botet J
    Med Clin (Barc); 2022 Jun; 158(11):550-555. PubMed ID: 35120767
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and efficacy of bariatric surgery in patients with advanced fibrosis.
    Singh T; Kochhar GS; Goh GB; Schauer P; Brethauer S; Kroh M; Aminian A; Lopez R; Dasarathy S; McCullough AJ
    Int J Obes (Lond); 2017 Mar; 41(3):443-449. PubMed ID: 27881858
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Nonalcoholic fatty liver disease: clinical and histological characteristics in obese who underwent bariatric surgery].
    Bitencourt AG; Cotrim HP; Alves E; Almeida AM; Barbosa DB; Santos AS; Lobo AP; Athayde LG; Rios A; Gouveia M; Freitas LA
    Acta Gastroenterol Latinoam; 2007 Dec; 37(4):224-30. PubMed ID: 18254260
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term Results of Bariatric Surgery for Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis Treatment in Morbidly Obese Japanese Patients.
    Uehara D; Seki Y; Kakizaki S; Horiguchi N; Tojima H; Yamazaki Y; Sato K; Yamada M; Uraoka T; Kasama K
    Obes Surg; 2019 Apr; 29(4):1195-1201. PubMed ID: 30542827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.